Abstract
Macleayins A (MA), a novel compound, was isolated from Macleaya cordata (Willd.) R. Br. and Macleaya microcarpa (Maxim.) Fedde. The plant species are the member of Papaveraceae family and have been used traditionally for diverse therapeutic purposes. According to the reported studies, the chemical constituents, as well as crude extracts of these plants, could attenuate the proliferation of several cancer cell lines, such as HL-60, A549, HepG2, and MCF-7. The current study aimed to investigate the anticervical cancer activity of MA and its related molecular mechanism. Isolation of MA was carried out using various column chromatographic methods, and its structure was elucidated with 1H NMR. The cytotoxicity of MA was determined against HeLa cell lines via CCK-8 assay. The cell proliferation, apoptosis, cell cycle, migration, and invasion were measured by EdU labeling, Annexin-V APC/7-AAD double staining, PI staining, and transwell assay, respectively. The protein expression levels of c-Myc, β-catenin, cyclin D1, and MMP-7 in the cells were evaluated by western blotting. The Wnt/β-catenin signaling cascade activation was verified using the Dual-Glo® Luciferase assay. We found that MA inhibited the growth of HeLa cells at 72 h (IC50 = 26.88 µM) via inducing apoptotic process, reduced the proliferation rate by 29.89%, and decreased the cells migration and invasion as compared to the untreated group. It arrested the cell cycle at the G1 phase and its treatment inhibited the expression of related proteins c-Myc, β-catenin, cyclin D1, and MMP-7 in the Wnt/β-catenin signaling cascade. Further, the Wnt/β-catenin signaling cascade activation in MA-treated HeLa cells was attenuated in a dose-dependent manner. These findings demonstrate the anticancer effects of MA on a mechanistic level, thus providing a basis for MA to become a potential candidate drug for resistance of cervical carcinoma.
Highlights
According to the report of Lancet Global Health 2019, about 570,000 cervical cancer cases and 311,000 cervical cancer deaths occurred in 2018 across the globe, with 106,000 cases and 48,000 deaths reported in China
To investigate the antitumor activity of Macleayins A (MA) obtained from M. microcarpa, we first evaluated the cytotoxicity of candidate compound, i.e., MA, on different cancer cell lines
We examined whether the reduced number of HeLa cells by MA was caused by inhibiting proliferation or inducing apoptosis
Summary
According to the report of Lancet Global Health 2019, about 570,000 cervical cancer cases and 311,000 cervical cancer deaths occurred in 2018 across the globe, with 106,000 cases and 48,000 deaths reported in China. According to the stage of disease at diagnosis, the treatment strategies of cervical carcinoma comprised of surgery, chemotherapy, immunotherapy, radiotherapy, and locally targeted therapy (Liu et al, 2020a; de Felice et al, 2021). Researchers are currently focusing on investigating the candidate drugs with relatively low toxicity for overcoming cervical carcinoma. Epidemiology and animal experiments have shown that various natural ingredients can block the occurrence and development of tumors. It is of theoretical value and of practical significance to search for antitumor drugs from plant active ingredients having high efficiency and low toxicity (Bich Ngoc et al, 2020)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
